Generics (U.K.) Ltd. manufactures generic pharmaceutical products. It makes generic drugs which includes acid reflux remedy Pepcid, antibiotic Cipro and allergy treatment Zyrtec. The firm also manufactures cytotoxics such as azathioprine and penicillin based antibiotics. The company was founded on April 29, 1981 and is headquartered in Potters Bar, the United Kingdom.

Ophirex, is developing a first in class drug that will help the 500,000 people who die or suffer amputations each year from venomous snakebite. 70% of those who die never even make it to the hospital for treatment. Because Ophirex's drug will be available in an oral formulation, all that will change. Our drug is a small molecule inhibitor that targets the most lethal component of venom, so it will be effective against the most dangerous snakes.

One Health Company is a social impact company that brings precision medicine, used in humans, to dogs with cancer. They offer genetic sequencing and diagnostic testing for the treatment of dog cancer.

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Beijing Kanemege Pharmaceutical Technology Co., Ltd., established on 2017-01-19, Business scope includes technology development,technical consulting,Technical Training,technology transfer,Technology Promotion,Technical Services;Medical Research and Experimental Development;Sales of chemical products(Does not contain dangerous chemicals and a class of precursor chemicals),Instrumentation,medical equipment(Ikind);Agent import and export;Technology Import and Export;Import and export.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA.

Hangzhou Rongli Pharmaceutical Technology Co., Ltd., established on 2002-06-06, Business scope includes licensed projects:Technology Import and Export;Import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Information Consulting Service(Not including licensing information consulting services);Health Consulting Services(Does not include medical services)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Pusan National University Hospital is a South Korean private company that operates as an university hospital.

Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and nutritional products. The company operates in two segments, Pharmaceuticals, and Nutritionals. The Nutritionals segment is operated through the company's subsidiary Mead Johnson Nutrition Company (Mead Johnson). The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business.

Jinan Yitong Urban Construction Group Co., Ltd., established on 2001-07-26, Business scope includes general contracting of municipal public works construction;Landscaping project;bridge engineering;Environmental Engineering;River and lake improvement project;Water Resources and Hydropower Engineering;City and road lighting engineering;civil Engineering;Earthwork;Municipal roads,Drainage network construction and maintenance;Building Material Development,Sales;Equipment(No special equipment)lease;Engineering Consulting.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Nantong Fayink High-tech Materials Technology Co., Ltd., established on 2004-05-10, Business scope includes baclofen,toremifene citrate,Carvedilol,Surfactant Manufacturing,Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Import and export;Technology Import and Export;Import and export agency(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:New material technology promotion service;Chemical product sales(No licensed chemical products)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Suzhou Unicon Pharmaceutical Technology Co., Ltd., established on 2020-06-19, Business scope includes licensed projects:Drug import and export;Import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Pharmaceutical special equipment sales;Sales of Class I Medical Devices;Sales of Class II Medical Devices(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ.

Xinchang County Diligent Biomedical Technology Co., Ltd., established on 2016-12-23, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Research and development of biopesticide technology;Bio-feed R&D;Biomass Energy Technology Services;Bio-organic fertilizer research and development;Biochemical product technology research and development;Sales of Class I Medical Devices;Resource recycling technology research and development;Internet of things technology research and development;Network technology service;Network Equipment Sales;Artificial intelligence application software development(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Oryzon Genomics is a biopharmaceutical company developing epigenetics-based therapeutics for patients with cancer and CNS disorders. Oryzon is able to identify and validate biomarkers and therapeutic targets through its epigenetic platform and turn them into advanced and personalized therapies. Oryzon Genomics has a growing portfolio, with two compounds in Phase II clinical trials: iadademstat (aka ORY-1001), a potent and selective LSD1 inhibitor for oncology, and vafidemstat (aka ORY-2001), a CNS optimized LSD1 inhibitor for the treatment of neurological diseases. The portfolio includes ORY-3001, a selective LSD1 inhibitor in preclinical development for the treatment of non-oncological diseases.

Pharma Mar SA is a biopharmaceutical holding company, which engages in research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It operates through the following segments: Oncology, Diagnostics, and RNAi. The Oncology segment focuses to the group undertakings whose object is to research, develop, and market anti-tumour drugs. The Diagnostics segment focuses in the development and marketing of diagnostic kits. The RNAi segment develops drugs with therapeutic activity based on reducing or silencing gene expression. The company was founded by José Maria Fernández de Sousa-Faro on April 30, 1986 and is headquartered in Colmenar Viejo, Spain.

Suzhou Yifan Pharmaceutical Co., Ltd., established on 2013-03-21, Business scope includes pharmaceuticals,raw material,Accessories,Pharmaceutical Intermediates,Cosmetics and disinfection products(Does not contain dangerous goods)research and development,Production,Sales,import and export;Technical Services;Import and export of medical technology;Imported drug sub-packaging,General Freight and Refrigerated Freight Forwarding,storage(In addition to dangerous goods)Serve.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Henan Provincial Peoples Hospital is a Chinese private company located in Zhengzhou. The firm operates as an hospital.